| Literature DB >> 24918543 |
Lingyun Xiao1, Haifeng Li2, Ju Zhang3, Fan Yang4, Aizhen Huang5, Jingjing Deng6, Ming Liang7, Fangli Ma8, Minghua Hu9, Zebo Huang10.
Abstract
Polyglutamine (polyQ) aggregation plays a pivotal role in the pathological process of Huntington's disease and other polyQ disorders. Therefore, strategies aiming at restoring dysfunction and reducing stresses mediated by polyQ toxicity are of therapeutic interest for proteotoxicity diseases. Salidroside, a glycoside from Rhodiola rosea, has been shown to have a variety of bioactivities, including antioxidant activity. Using transgenic Caenorhabditis elegans models, we show here that salidroside is able to reduce neuronal death and behavioral dysfunction mediated by polyQ expressed in ASH neurons, but the neuroprotective effect is not associated with prevention of polyQ aggregation per se. Further experiments reveal that the neuroprotective effect of salidroside in C. elegans models involves its antioxidant capabilities, including decrease of ROS levels and paraquat-induced mortality, increase of antioxidant enzyme activities and reduction of lipid peroxidation. These results demonstrate that salidroside exerts its neuroprotective function against polyQ toxicity via oxidative stress pathways.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24918543 PMCID: PMC6270757 DOI: 10.3390/molecules19067757
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Effect of salidroside on the survival of ASH neurons in C. elegans HA759. (A) Micrographs of HA759 nematodes expressing Htt-Q150 in ASH neurons. Death of ASH neurons is assessed by loss of bilateral GFP fluorescence. Scale bars, 20 μm; (B) Survival rate of ASH neurons after salidroside treatment. The nematodes were treated with salidroside from L1 at indicated concentrations at 20 °C for 72 h and then subjected to neuronal survival assay. Data are representative of three independent experiments and presented as mean ± SD. *p < 0.05.
Figure 2Effect of salidroside on chemosensory behavior in C. elegans. Nematodes were treated with salidroside from L1 at indicated concentrations at 20 °C for 72 h and then subjected to chemosensory assay. (A) HA759 nematodes. Data are presented as mean ± SEM of three independent experiments. * p < 0.05; (B) N2 nematodes. Data are representative of three independent experiments and presented as mean ± SD.
Figure 3Effect of salidroside on polyQ aggregation. (A) Salidroside did not prevent in vitro polyQ aggregation. PolyQ40was first incubated with salidroside or EGCG at 37 °C for indicated times and then mixed with ThT prior to fluorescence determination; (B) Salidroside did not inhibit polyQ aggregation in C. elegans. AM141 nematodes were treated from L1 with salidroside or EGCG and scored for YFP positive aggregates at 24, 48 and 72 h, respectively. Data are representative of three independent experiments and presented as mean ± SD.
Figure 4Effect of salidroside on ROS level and oxidative survival in C. elegans. (A, B) Salidroside decreased ROS level of HA759 and N2 nematodes. The nematodes were treated from L1 with salidroside at 20 °C for 72 h and then lysed for determination of ROS level by DCF assay every 10 min for 60 min. Data are representative of three independent experiments and presented as mean ± SD; (C, D) Salidroside increased the survival rates of paraquat-intoxicated polyQ HA759 and wild-type N2 nematodes, respectively. After treatment with salidroside at 20 °C for 48 h from young adult stage, the nematodes were exposed to 0.1 M paraquat and scored every 12 h for survival rate. Representative Kaplan–Meier survival curves are shown from three independent experiments.
Effect of salidroside on the activity of antioxidant enzymes and malondialdehyde content in C. elegans.
| Strain | Salidroside (μM) | Antioxidant Enzyme Activity a | MDA Content b | |
|---|---|---|---|---|
| SOD | CAT | |||
| HA759 | 0 | 16.2 ± 0.35 | 870 ± 78 | 0.66 ± 0.037 |
| 50 | 20.6 ± 1.37 | 1104 ± 74 | 0.51 ± 0.084 | |
| 100 | 21.5 ± 1.78 c | 1427 ± 188 c | 0.45 ± 0.14 | |
| 200 | 21.3 ± 0.63 c | 1418 ± 37 c | 0.24 ± 0.031 c | |
| N2 | 0 | 19.01 ± 0.24 | 1147 ± 26 | 0.59 ± 0.060 |
| 50 | 19.42 ± 0.78 | 1063 ± 80 | 0.45 ± 0.15 | |
| 100 | 18.30 ± 0.62 | 1066 ± 90 | 0.43 ±0.061 | |
| 200 | 20.06 ± 0.90 | 1176 ± 11 | 0.30 ± 0.059 c | |
a SOD, U/mg protein; CAT, U/μg protein; b MDA, μM/mg; cp < 0.05.